Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature

Type I interferons (IFN-I) and their cognate receptor, the IFNAR1/2 heterodimer, are critical components of the innate immune system in humans. They have been widely explored in the context of viral infection and autoimmune disease where they play key roles in protection against infection or shaping...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jamie A. Sugrue, Nollaig M. Bourke, Cliona O’Farrelly
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/908e3711945840ccbe2b6a7f880b7e1d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:908e3711945840ccbe2b6a7f880b7e1d
record_format dspace
spelling oai:doaj.org-article:908e3711945840ccbe2b6a7f880b7e1d2021-12-01T18:55:36ZType I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature1664-322410.3389/fimmu.2021.757249https://doaj.org/article/908e3711945840ccbe2b6a7f880b7e1d2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.757249/fullhttps://doaj.org/toc/1664-3224Type I interferons (IFN-I) and their cognate receptor, the IFNAR1/2 heterodimer, are critical components of the innate immune system in humans. They have been widely explored in the context of viral infection and autoimmune disease where they play key roles in protection against infection or shaping disease pathogenesis. A false dichotomy has emerged in the study of IFN-I where interferons are thought of as either beneficial or pathogenic. This ‘good or bad’ viewpoint excludes more nuanced interpretations of IFN-I biology - for example, it is known that IFN-I is associated with the development of systemic lupus erythematosus, yet is also protective in the context of infectious diseases and contributes to resistance to viral infection. Studies have suggested that a shared transcriptomic signature underpins both potential resistance to viral infection and susceptibility to autoimmune disease. This seems to be particularly evident in females, who exhibit increased viral resistance and increased susceptibility to autoimmune disease. The molecular mechanisms behind such a signature and the role of sex in its determination have yet to be precisely defined. From a genomic perspective, several single nucleotide polymorphisms (SNPs) in the IFN-I pathway have been associated with both infectious and autoimmune disease. While overlap between infection and autoimmunity has been described in the incidence of these SNPs, it has been overlooked in work and discussion to date. Here, we discuss the possible contributions of IFN-Is to the pathogenesis of infectious and autoimmune diseases. We comment on genetic associations between common SNPs in IFN-I or their signalling molecules that point towards roles in protection against viral infection and susceptibility to autoimmunity and propose that a shared transcriptomic and genomic immunological signature may underlie resistance to viral infection and susceptibility to autoimmunity in humans. We believe that defining shared transcriptomic and genomic immunological signatures underlying resistance to viral infection and autoimmunity in humans will reveal new therapeutic targets and improved vaccine strategies, particularly in females.Jamie A. SugrueNollaig M. BourkeCliona O’FarrellyCliona O’FarrellyFrontiers Media S.A.articleinfectionautoimmunityviral resistancegeneticssexual dimorphismtype I interferonsImmunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic infection
autoimmunity
viral resistance
genetics
sexual dimorphism
type I interferons
Immunologic diseases. Allergy
RC581-607
spellingShingle infection
autoimmunity
viral resistance
genetics
sexual dimorphism
type I interferons
Immunologic diseases. Allergy
RC581-607
Jamie A. Sugrue
Nollaig M. Bourke
Cliona O’Farrelly
Cliona O’Farrelly
Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature
description Type I interferons (IFN-I) and their cognate receptor, the IFNAR1/2 heterodimer, are critical components of the innate immune system in humans. They have been widely explored in the context of viral infection and autoimmune disease where they play key roles in protection against infection or shaping disease pathogenesis. A false dichotomy has emerged in the study of IFN-I where interferons are thought of as either beneficial or pathogenic. This ‘good or bad’ viewpoint excludes more nuanced interpretations of IFN-I biology - for example, it is known that IFN-I is associated with the development of systemic lupus erythematosus, yet is also protective in the context of infectious diseases and contributes to resistance to viral infection. Studies have suggested that a shared transcriptomic signature underpins both potential resistance to viral infection and susceptibility to autoimmune disease. This seems to be particularly evident in females, who exhibit increased viral resistance and increased susceptibility to autoimmune disease. The molecular mechanisms behind such a signature and the role of sex in its determination have yet to be precisely defined. From a genomic perspective, several single nucleotide polymorphisms (SNPs) in the IFN-I pathway have been associated with both infectious and autoimmune disease. While overlap between infection and autoimmunity has been described in the incidence of these SNPs, it has been overlooked in work and discussion to date. Here, we discuss the possible contributions of IFN-Is to the pathogenesis of infectious and autoimmune diseases. We comment on genetic associations between common SNPs in IFN-I or their signalling molecules that point towards roles in protection against viral infection and susceptibility to autoimmunity and propose that a shared transcriptomic and genomic immunological signature may underlie resistance to viral infection and susceptibility to autoimmunity in humans. We believe that defining shared transcriptomic and genomic immunological signatures underlying resistance to viral infection and autoimmunity in humans will reveal new therapeutic targets and improved vaccine strategies, particularly in females.
format article
author Jamie A. Sugrue
Nollaig M. Bourke
Cliona O’Farrelly
Cliona O’Farrelly
author_facet Jamie A. Sugrue
Nollaig M. Bourke
Cliona O’Farrelly
Cliona O’Farrelly
author_sort Jamie A. Sugrue
title Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature
title_short Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature
title_full Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature
title_fullStr Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature
title_full_unstemmed Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature
title_sort type i interferon and the spectrum of susceptibility to viral infection and autoimmune disease: a shared genomic signature
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/908e3711945840ccbe2b6a7f880b7e1d
work_keys_str_mv AT jamieasugrue typeiinterferonandthespectrumofsusceptibilitytoviralinfectionandautoimmunediseaseasharedgenomicsignature
AT nollaigmbourke typeiinterferonandthespectrumofsusceptibilitytoviralinfectionandautoimmunediseaseasharedgenomicsignature
AT clionaofarrelly typeiinterferonandthespectrumofsusceptibilitytoviralinfectionandautoimmunediseaseasharedgenomicsignature
AT clionaofarrelly typeiinterferonandthespectrumofsusceptibilitytoviralinfectionandautoimmunediseaseasharedgenomicsignature
_version_ 1718404643052060672